Study title:
Czerwionka-Szaflarska-M, Sadowska-Krawczenko-I, Korbal-P.
M. Czerwionka-Szaflarska, Katedra i Klinika Pediatrii, Alergologii i Gastroenterologii, Akademia Medyczna im. L. Rydygiera, Bydgoszcz, Poland.
Gastroesophageal reflux in preterm infants.
Pediatria Polska {PEDIATR-POL}, 2005, Vol/Iss/Pg. 80/9 (719-726),Czerwionka-Szaflarska-M, Sadowska-Krawczenko-I, Korbal-P.
M. Czerwionka-Szaflarska, Katedra i Klinika Pediatrii, Alergologii i Gastroenterologii, Akademia Medyczna im. L. Rydygiera, Bydgoszcz, Poland.
Gastroesophageal reflux in preterm infants.
Pediatria Polska {PEDIATR-POL}, 2005, Vol/Iss/Pg. 80/9 (719-726),
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Digestive System Diseases
|
Brands: Please see report, Please see report |
MAH holders: Please see report, Please see report |
Assessment: |
Active substance: TRIMEBUTINE |
ATC code: A03AA05 |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|